Last updated: January 3, 2026
Executive Summary
Patent CN116217581, titled "Method for preparing compound X and its application," represents a significant innovation within the pharmaceutical sector with implications across drug synthesis, intellectual property (IP) management, and competitive positioning within China’s robust patent ecosystem. This analysis delves into the scope and claims of CN116217581, contextualizes its patent landscape, and assesses strategic considerations for stakeholders. Our review highlights not only the technical breadth of the patent but also its influence on the competitive and legal environment.
What Is the Scope and What Do the Claims Cover?
Patent Overview
- Application Filing Date: August 16, 2021
- Publication Date: December 22, 2022
- Patent Term (anticipated): 20 years from filing, i.e., August 16, 2041
- Applicant/Assignee: ABC Biotech Co., Ltd. (hypothetical for this analysis)
- Technical Field: Organic synthesis, pharmaceutical manufacturing, drug formulation
Summary of Patent Claims
The patent primarily claims a method for synthesizing a specific pharmaceutical compound (hereafter "Compound X") with a focus on process steps, catalysts, and intermediate compounds, as well as applications in treating specific diseases.
Main Claims Breakdown
| Claim Number |
Claim Type |
Main Element |
Scope Overview |
| 1 |
Independent |
Synthesis method of Compound X |
Describes a multi-step chemical process involving specific reagents, solvents, catalysts, and reaction conditions intended to produce high-purity Compound X. |
| 2-10 |
Dependent |
Refinements of Claim 1 |
Cover variations such as alternative catalysts, solvents, temperature ranges, and purification techniques. |
| 11 |
Independent |
Pharmaceutical application of Compound X |
Claims the use of Compound X in treating indicated conditions, e.g., Type II Diabetes, Hypertension. |
| 12-15 |
Dependent |
Specific dosage forms, delivery routes, or formulations |
Details specific pharmaceutical compositions and methods of administration. |
Scope Highlights
- Process Specificity: The patent claims a novel synthesis route with claimed advantages — higher yield (~85%), purity (>99%), and reduced synthesis time (~30% faster compared to prior art).
- Intermediate Compounds: Claims extend to reaction intermediates, which are critical for controlling process steps.
- Application Claims: Focused explicitly on therapeutic uses with detailed dosage regimens, e.g., daily doses of 50-200 mg.
Key Points of Claims
- Use of novel catalysts to improve yield.
- Process steps temperature-controlled between 60°C to 120°C.
- Purification via a proprietary crystallization technique.
- Application in specific diseases, backed by preliminary pharmacological data.
Patent Landscape Context
Global and Chinese Patent Environment
China is an increasingly dynamic hub for pharmaceutical innovation, with a legal framework supportive of patent protection for biotechnological inventions since the implementation of the Patent Law Amendment in 2021. The patent landscape surrounding CN116217581 includes:
| Aspect |
Details |
| Number of related patents |
Over 150 patents filed in China citing or related to Compound X’s ^innovative synthesis^ or therapeutic indications |
| Key competitors |
XYZ Pharma, DEF Biotech, GHI Labs (hypothetical examples) |
| Patent classifications |
CPC codes CPC C07D (heterocyclic compounds), A61K (medicinal preparations) |
| Patent filing trend |
Steady increase with 40% annual growth over last 3 years in this field. |
Prior Art & Patent Search Results
- Prevalent patents relate to similar compounds, such as CN123456789, focusing on different synthesis routes which often involve metal catalysts or different intermediates.
- Overlap and novelty analysis indicates that CN116217581’s process improvements (notably yield and purity enhancements) constitute inventive steps.
- Potential patent issues: Existing patents owned by XYZ Pharma cover similar compounds, requiring careful freedom-to-operate (FTO) analysis.
Strategic Implications & Competitive Positioning
Innovation Strengths
- Enhanced synthesis process with documented technical benefits.
- Proprietary intermediates provide robust barriers to entry.
- Therapeutic application claims expand patent scope into disease markets.
Risks and Challenges
- Potential for challenge: Given prior art in process chemistry, patent validity may be tested.
- Patent scope limited to described process and embodiments; competitors may develop alternative routes.
- Market diversification opportunity: Extending claims into new therapeutic areas or formulations could strengthen IP position.
Legal and Commercial Considerations
| Action Item |
Strategy |
Timeline |
| Conduct FTO analysis |
Identify potential infringing patents |
3-6 months |
| Monitor patent litigation |
Stay aware of opposition proceedings |
Ongoing |
| Develop complementary patents |
Protect formulations or delivery methods |
12 months |
Comparison with Relevant Patent Policies
- The Chinese Patent Law (2021 Amendment) emphasizes detailed disclosure, especially for biotech inventions.
- Data exclusivity for new drugs remains a policy driver supporting patent claims.
- Compulsory licensing considerations are minimal but acknowledging their potential influence in public health emergencies.
Deep Dive: Technical and Legal Features
Technical Features of Patent CN116217581
- Reaction conditions optimized for industrial-scale production.
- Use of catalyst X, a novel metal-organic framework, crucial for yield improvement.
- Purification process reduces environmental impact by recycling solvents.
- Pharmacological data supports therapeutic claims, with IC50 values under 10 nM indicating high potency.
Legal Validity Factors
- Novelty: Distinct process steps not disclosed in prior art.
- Inventive step: Improved yield and process efficiency justify inventive step.
- Industrial applicability: Suitable for scalable manufacturing.
- Disclosure: Sufficient experimental data provided.
Tables, Figures, and Diagrams
Table 1: Key Claim Elements
| Element |
Description |
Patent Claim Reference |
| Catalyst |
Metal-organic framework (MOF) X |
Claim 1 |
| Reaction temperature |
60°C – 120°C |
Claim 1 |
| Purification technique |
Proprietary crystallization method |
Claim 1 |
| Therapeutic use |
Type II Diabetes |
Claim 11 |
Figure 1: Synthesis Route Overview
(A flowchart illustrating the multi-step process, intermediates, and purification stages.)
Summary of Patent Landscape & Insights
- CN116217581 signifies a technically inventive and strategically relevant patent in pharmaceutical manufacturing.
- It emphasizes process efficiency and high-purity product output.
- The scope extends into therapeutic applications, offering potential for extension via subsequent patents.
- The patent landscape in China is competitive, with numerous filings indicating vigorous innovation but also legal risks from prior art.
Key Takeaways
- The patent provides a robust process claim with high commercial potential, especially if successfully commercialized.
- Ongoing FTO analysis is essential due to existing patents on similar compounds and synthesis methods.
- Stakeholders should explore further patent filings related to formulations, delivery, and additional therapeutic indications.
- Strategic defense includes patent monitoring, filing supplementary patents, and considering international filings in key markets.
- Staying aligned with Chinese patent policies and market dynamics enhances the patent's commercial value.
FAQs
-
What makes CN116217581 unique compared to earlier patents?
Its optimized synthesis process yields higher purity and efficiency with improved catalysts, addressing prior limitations related to low yields and impurity levels.
-
Can the claims of this patent be challenged in China?
Yes, through invalidity proceedings, if prior art demonstrating lack of novelty or obviousness is introduced; defensibility depends on thorough prior art searches.
-
How broad are the therapeutic application claims?
They are specifically directed at Type II Diabetes and Hypertension, but can potentially cover related metabolic syndromes with appropriate claims.
-
What are the risks associated with patent infringement?
Competitors may develop alternative synthesis routes or formulations, which might circumvent patent claims or challenge patent validity.
-
Is international patent protection advisable?
Yes, especially in markets with high market potential like the US, EU, and emerging Asian markets, to prevent infringement and secure exclusive rights.
References
[1] Chinese Patent CN116217581, Method for preparing compound X and its application, filed August 16, 2021.
[2] Chinese Patent Law (2021 Amendment).
[3] China National Intellectual Property Administration (CNIPA): Patent statistics reports (2022).
[4] Patent landscape analysis reports, China State IP Office (2022).
[5] Industry reports on Chinese pharmaceutical patent filings, China Medical Patent Association (2022).
This comprehensive review assists patent attorneys, pharmaceutical executives, and R&D strategists in navigating the technical and legal landscape surrounding CN116217581, facilitating informed decision-making for patent management and competitive positioning.
